These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24649821)

  • 1. microRNAs: a new class of breast cancer biomarkers.
    Mulrane L; Klinger R; McGee SF; Gallagher WM; O'Connor DP
    Expert Rev Mol Diagn; 2014 Apr; 14(3):347-63. PubMed ID: 24649821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs in Breast Cancer: Diagnostic and Therapeutic Potential.
    Asiaf A; Ahmad ST; Arjumand W; Zargar MA
    Methods Mol Biol; 2018; 1699():23-43. PubMed ID: 29086366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer.
    Andorfer CA; Necela BM; Thompson EA; Perez EA
    Trends Mol Med; 2011 Jun; 17(6):313-9. PubMed ID: 21376668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased serum miR-181a is a potential new tool for breast cancer screening.
    Guo LJ; Zhang QY
    Int J Mol Med; 2012 Sep; 30(3):680-6. PubMed ID: 22692639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in breast cancer pathogenesis.
    Götte M
    Minerva Ginecol; 2010 Dec; 62(6):559-71. PubMed ID: 21079577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiRNAs as biomarkers and therapeutic targets in cancer.
    Heneghan HM; Miller N; Kerin MJ
    Curr Opin Pharmacol; 2010 Oct; 10(5):543-50. PubMed ID: 20541466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in the diagnosis and prognosis of breast cancer and their therapeutic potential (review).
    Zhang K; Zhang Y; Liu C; Xiong Y; Zhang J
    Int J Oncol; 2014 Sep; 45(3):950-8. PubMed ID: 24913679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Searching for candidate microRNA biomarkers in detection of breast cancer: a meta-analysis.
    Lv M; Zhu X; Chen W; Zhao J; Tang J
    Cancer Biomark; 2013; 13(5):395-401. PubMed ID: 24440980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNAs: macro-utility as markers of prostate cancer?
    Selth LA; Tilley WD; Butler LM
    Endocr Relat Cancer; 2012 Aug; 19(4):R99-R113. PubMed ID: 22492480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.
    Corsini LR; Bronte G; Terrasi M; Amodeo V; Fanale D; Fiorentino E; Cicero G; Bazan V; Russo A
    Expert Opin Ther Targets; 2012 Apr; 16 Suppl 2():S103-9. PubMed ID: 22443195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients.
    Kumar S; Keerthana R; Pazhanimuthu A; Perumal P
    Indian J Biochem Biophys; 2013 Jun; 50(3):210-4. PubMed ID: 23898484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers.
    Zen K; Zhang CY
    Med Res Rev; 2012 Mar; 32(2):326-48. PubMed ID: 22383180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.
    Shi M; Guo N
    Cancer Treat Rev; 2009 Jun; 35(4):328-34. PubMed ID: 19171434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA in colorectal cancer: new perspectives for diagnosis, prognosis and treatment.
    Bonfrate L; Altomare DF; Di Lena M; Travaglio E; Rotelli MT; De Luca A; Portincasa P
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):311-20. PubMed ID: 24078989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs are novel biomarkers of colorectal cancer.
    Aslam MI; Taylor K; Pringle JH; Jameson JS
    Br J Surg; 2009 Jul; 96(7):702-10. PubMed ID: 19526617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer.
    Zandberga E; Kozirovskis V; Ābols A; Andrējeva D; Purkalne G; Linē A
    Genes Chromosomes Cancer; 2013 Apr; 52(4):356-69. PubMed ID: 23404859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs in cancer management and their modulation by dietary agents.
    Karius T; Schnekenburger M; Dicato M; Diederich M
    Biochem Pharmacol; 2012 Jun; 83(12):1591-601. PubMed ID: 22342289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A panel of five circulating microRNAs as potential biomarkers for prostate cancer.
    Chen ZH; Zhang GL; Li HR; Luo JD; Li ZX; Chen GM; Yang J
    Prostate; 2012 Sep; 72(13):1443-52. PubMed ID: 22298030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).
    Allegra A; Alonci A; Campo S; Penna G; Petrungaro A; Gerace D; Musolino C
    Int J Oncol; 2012 Dec; 41(6):1897-912. PubMed ID: 23026890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomics in noninvasive breast cancer.
    Zhang AH; Sun H; Qiu S; Wang XJ
    Clin Chim Acta; 2013 Sep; 424():3-7. PubMed ID: 23669185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.